New research supports sofosbuvir in combination with other antivirals for COVID-19
Columbia Engineering researchers report that Sofosbuvir-terminated RNA is more resistant to the proofreader of SARS-CoV-2, the virus that causes COVID-19, than Remdesivir-terminated RNA. The results of the new study, published ...
Oct 6, 2020
0
17